Abstract
Watch the video or read the poster to learn: Understanding diversity in HEK cell lineages Significance of media screening in AAV process development Factors driving performance beyond titerImportance of adaptation strategy in media screening Jennifer Schieber is a senior R&D scientist for Thermo Fisher Scientific. She’s been a part of Thermo Fisher Scientific since 2020 and joined to enable product development to ensure customers have the necessary tools to help create a healthier world. She earned a PhD in pharmacology from The State University of New York at Buffalo, focused on the neuronal basis of opiate addiction, utilizing preclinical models and viral-mediated gene therapy to target changes in the brain. Her current focus is on development of products and solutions to enhance therapeutic potential of gene therapy manufacturing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
